Bibloc

Leaflet attached to the packaging: patient information

Warning! Keep the leaflet, information on the immediate packaging in a foreign language!

Bibloc(BisoHEXAL 1.25 mg)

1.25 mg, coated tablets

Bisoprolol fumarate
Bibloc and BisoHEXAL 1.25 mg are different trade names for the same medicine.

You should read the contents of the leaflet before taking the medicine, as it contains important information for the patient.

• You should keep this leaflet, so that you can read it again if you need to.
• If you have any doubts, you should consult a doctor or pharmacist.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor, pharmacist, or nurse. See section 4.

Table of contents of the leaflet:

• 1. What is Bibloc and what is it used for
• 2. Important information before taking Bibloc
• 3. How to take Bibloc
• 4. Possible side effects
• 5. How to store Bibloc
• 6. Contents of the packaging and other information

1. What is Bibloc and what is it used for

Bibloc belongs to a group of medicines called beta-blockers. They protect the heart from excessive activity.
Bibloc is used to treat:

• heart failure, which causes shortness of breath during exertion or fluid retention in the body. In this case, Bibloc may be used as additional treatment for heart failure, which is being treated with other medicines.

2. Important information before taking Bibloc

When not to take Bibloc

• If the patient is allergic to bisoprolol fumarate or any of the other ingredients of this medicine (listed in section 6).
• If the patient has cardiogenic shock - a severe heart disorder with rapid, weak pulse, low blood pressure, cold, moist skin, weakness, and fainting.
• If the patient has ever had wheezing or severe asthma, as breathing difficulties may occur.
• If the patient has a slow heart rate (less than 60 beats per minute). In case of doubt, consult a doctor.
• If the patient has very low blood pressure.
• If the patient has severe circulatory disorders (which can cause tingling in the fingers and toes or their discoloration).
• If the patient has severe heart rhythm disorders.
• If the patient has suddenly developed heart failure or existing heart failure that is not controlled and requires hospital treatment.
• If the patient has a buildup of acids in the body, diagnosed as metabolic acidosis. The doctor will provide information on this.
• If the patient has a pheochromocytoma (a tumor of the adrenal gland) that is not being treated.

In case of any doubts, consult a doctor.

Warnings and precautions

Before starting to take Bibloc, you should consult a doctor:

• if you have wheezing or difficulty breathing (asthma), you should also use bronchodilators. A higher dose of beta-2-mimetic may be necessary.
• if you have diabetes. Bibloc tablets may mask the symptoms of low blood sugar (such as rapid heart rate, palpitations, or excessive sweating).
• if you do not eat foods with a constant consistency.
• if you are being treated for allergies. Bibloc may increase sensitivity to allergens and worsen the severity of hypersensitivity reactions. Adrenaline treatment may not be effective and may require a higher dose.
• if you have a first-degree atrioventricular block (conduction disorder in the heart).
• if you have Prinzmetal's angina (chest pain caused by coronary artery spasm).
• if you have circulatory disorders in your hands and feet.
• if you are going to have surgery, you should inform your doctor, hospital staff, or dentist about the medicines you are taking.
• if you have (or have had) psoriasis (a recurring disease characterized by skin peeling and dry rash).
• if you have a pheochromocytoma (a tumor of the adrenal gland). Before prescribing Bibloc, the doctor will need to provide appropriate treatment.
• if you have thyroid function disorders. Bisoprolol tablets may mask the symptoms of hyperthyroidism.

There is currently a lack of therapeutic experience with the use of Bibloc in heart failure in the following patients:

• with type 1 diabetes, treated with insulin
• with severe kidney disease
• with severe liver disease
• with certain heart diseases
• who have had a heart attack in the last 3 months.

Treatment of heart failure with Bibloc requires systematic medical monitoring. This is absolutely necessary, especially at the beginning of treatment and after its completion.
Do not stop taking Bibloc suddenly without a compelling reason.
If any of the warnings apply to you or have applied in the past, consult a doctor or pharmacist.

Bibloc and other medicines

Tell your doctor or pharmacist about all the medicines you are currently taking or have recently taken, as well as any medicines you plan to take. This also applies to medicines that are available without a prescription. Certain medicines should not be taken at the same time as Bibloc, and others may require changes, such as dose adjustments.
In any case, inform your doctor about taking or receiving the following medicines in addition to Bibloc:

• medicines used to control blood pressure or heart function disorders (such as amiodarone, amlodipine, clonidine, digitalis glycosides, diltiazem, disopyramide, felodipine, flecainide, lidocaine, methyldopa, moxonidine, phenytoin, propafenone, quinidine, rilmenidine, verapamil);
• sedatives and medicines used to treat psychosis (a mental illness), such as barbiturates (also used to treat epilepsy), phenothiazines (also used to treat vomiting and nausea);
• medicines used to treat depression, such as tricyclic antidepressants, MAO-A inhibitors;
• medicines used for anesthesia during surgery (see also "Warnings and precautions");
• certain painkillers (such as acetylsalicylic acid, diclofenac, indomethacin, ibuprofen, naproxen);
• medicines used to treat asthma, nasal congestion, or certain eye diseases, such as glaucoma (increased pressure in the eyeball) or pupil dilation;
• certain medicines used to treat shock (such as adrenaline, dobutamine, noradrenaline);
• mefloquine (a medicine used to treat malaria);
• rifampicin (an antibiotic);
• ergotamine derivatives (used to treat migraines). All these medicines and Bibloc may affect blood pressure and/or heart function.
• insulin or other anti-diabetic medicines. There is a possibility of increased glucose-lowering effect and masking of symptoms of low blood sugar.

Bibloc and alcohol

Alcohol may increase the dizziness and drowsiness caused by Bibloc. In this case, you should avoid drinking alcohol.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult a doctor before taking this medicine. Bibloc may have a harmful effect on the course of pregnancy and/or the fetus. The risk of premature birth, miscarriage, low blood sugar in the child, and slowed heart rate increases. The medicine may also affect the development of the child. Therefore, Bibloc should not be taken during pregnancy.
It is not known whether bisoprolol passes into breast milk, so it is not recommended to take Bibloc while breastfeeding.

Driving and operating machines

The medicine may cause fatigue, drowsiness, or dizziness. If these symptoms occur, do not drive vehicles and/or operate machines. Keep in mind that such symptoms may occur, especially at the beginning of treatment, when changing to another medicine, and when consuming alcohol.

Bibloc contains lactose and sodium

If you have previously been diagnosed with intolerance to certain sugars, you should contact your doctor before taking the medicine.
This medicine contains less than 1 mmol (23 mg) of sodium per coated tablet, which means the medicine is considered "sodium-free".

3. How to take Bibloc

This medicine should always be taken according to the doctor's or pharmacist's recommendations. In case of doubts, consult a doctor or pharmacist.
The doctor will inform you how many tablets to take. The medicine should be taken in the morning, before, during, or after breakfast. The tablet(s) should be swallowed with a small amount of water. Do not chew or crush the tablets.
The usual dose is:

Heart failure (reduced heart contraction force)

Before starting to take Bibloc, the patient usually already takes an ACE inhibitor, diuretic, or digitalis glycoside (a heart medicine and antihypertensive).
The dose of the medicine will be gradually increased until the appropriate dose for the patient is reached:
1.25 mg once a day for 1 week. If this dose is well tolerated, it can be increased to:
2.5 mg once a day for the next week. If this dose is well tolerated, it can be increased to:
3.75 mg once a day for the next week. If this dose is well tolerated, it can be increased to:
5 mg once a day for 4 consecutive weeks. If this dose is well tolerated, it can be increased to:
7.5 mg once a day for 4 consecutive weeks. If this dose is well tolerated, it can be increased to:
10 mg once a day (maintenance dose).
The maximum dose is 10 mg once a day.
The doctor will determine the optimal dose for the patient based on, among other things, side effects. After the first dose of 1.25 mg, the doctor will check the patient's blood pressure, heart rate, and heart function.
Liver or kidney function disorders
The doctor will increase the dose of the medicine with caution.
Elderly
Dose adjustment is not usually necessary.
If you feel that the effect of Bibloc is too strong or too weak, you should inform your doctor or pharmacist.
Duration of treatment
Bibloc is usually taken long-term.

Use in children and adolescents

Due to the lack of studies on the effect of Bibloc in children and adolescents, its use is not recommended in this age group.

Taking a higher dose of Bibloc than recommended

In case of unintentional ingestion of a higher dose than recommended, you should immediately contact
a doctor or pharmacist. You should take the remaining tablets or this leaflet with you, so that the medical staff knows what medicine has been taken. Symptoms of overdose may include dizziness, drowsiness, fatigue, shortness of breath and/or wheezing. Slow heart rate, low blood pressure, inadequate heart contraction force, and low blood sugar (which can cause hunger, excessive sweating, and palpitations) may also occur.

Missing a dose of Bibloc

Do not take a double dose to make up for a missed dose. Take the usual dose as soon as you remember, and return to the normal dosing schedule the next day.

Stopping treatment with Bibloc

Do not stop taking Bibloc suddenly. If treatment is stopped abruptly, the disease may worsen. The dose of the medicine should be gradually reduced over several weeks, according to the doctor's recommendation.
In case of any further doubts about taking this medicine, consult a doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
If a side effect is serious, occurs suddenly, or worsens rapidly, you should immediately contact a doctor to prevent severe reactions.
The most serious side effects are related to heart function:

• slow heart rate (may occur more frequently than in 1 in 10 people) worsening of existing heart failure (may occur less frequently than in 1 in 10 people)
• slow or irregular heart rate (may occur less frequently than in 1 in 100 people)

If you experience dizziness, weakness, or difficulty breathing, you should contact a doctor as soon as possible.
If you experience severe hypersensitivity reactions, which may include swelling of the face, neck, tongue, lips, or throat, or difficulty breathing, you should immediately contact a doctor.
The following side effects are listed below by frequency of occurrence:
Common (may occur less frequently than in 1 in 10 people):

• fatigue, exhaustion
• dizziness
• headache
• feeling of coldness or numbness in the fingers and toes, ears, and nose; more frequent occurrence of cramping leg pain while walking
• very low blood pressure (hypotension), especially in patients with heart failure
• nausea, vomiting
• diarrhea
• constipation

Uncommon (may occur less frequently than in 1 in 100 people):

• decrease in blood pressure when standing up, which may cause dizziness, drowsiness, or fainting
• sleep disorders
• depression
• irregular heart rate
• breathing difficulties in patients with asthma or a history of breathing disorders
• muscle weakness and cramps

Rare (may occur less frequently than in 1 in 1,000 people):

• nightmares
• hallucinations
• fainting
• hearing impairment
• inflammation of the nasal mucosa, causing a runny nose with irritation
• skin allergic reactions (such as itching, sudden redness of the skin, rash)
• dryness of the conjunctiva due to reduced tear secretion (which can be very troublesome in patients using contact lenses)
• liver inflammation, causing abdominal pain, loss of appetite, and sometimes jaundice with yellowing of the eyes and skin, as well as dark urine
• reduced sexual potency (impotence)
• increased lipid levels in the blood (triglycerides) and increased liver enzyme activity

Very rare (may occur less frequently than in 1 in 10,000 people):

• worsening of psoriasis symptoms or occurrence of a similar, dry, flaky rash, as well as hair loss
• itching or redness of the eyes (conjunctivitis)

Reporting side effects

If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of the medicine.

5. How to store Bibloc

The medicine should be stored in a place that is out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
There are no special precautions for storage.
Translation of some information on the immediate packaging:
Ch.-B./verwendbar bis: see imprint – batch number/expiry date: see embossing.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Bibloc contains

• The active substance is bisoprolol fumarate. Each coated tablet contains 1.25 mg of bisoprolol fumarate.
• The other ingredients are: calcium hydrogen phosphate, microcrystalline cellulose, maize starch, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, coating: lactose monohydrate, hypromellose, titanium dioxide (E 171), macrogol 4000.

What Bibloc looks like and what the packaging contains

White, round, coated tablets marked "BIS 1.25" on one side.
The coated tablets are packaged in blisters of OPA/Al/PVC/Al foil in a cardboard box. The blisters contain 20, 25, 40, 50, 60, or 100 tablets.
For more detailed information, contact the marketing authorization holder or parallel importer.

Marketing authorization holder in Germany, the country of export:

Hexal AG
Industriestraße 25
83607 Holzkirchen
Germany

Manufacturer:

Lek S.A.
ul. Podlipie 16
Stryków 95-010
Poland
Salutas Pharma GmbH
Otto-von-Guericke-Allee 1
39179 Barleben
Germany
ROWA Pharmaceuticals Limited
Newtown, Bantry, Co. Cork
Ireland
Lek Pharmaceuticals d.d
Verovskova ulica 57
1526 Ljubljana
Slovenia

Parallel importer:

Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź

Repackaged by:

Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Marketing authorization number in Germany, the country of export: 71878.00.00
Parallel import authorization number: 33/24

Date of leaflet approval: 25.01.2024

[Information about the trademark]